|
**Overview**: Histopathology PAS Stain Panel**Introduction**: The Histopathology PAS Stain Panel is a diagnostic tool designed to detect fungal/mucopolysaccharide deposits using FFPE tissue. In India, PAS stain is essential for identifying fungal infections (candida, aspergillus, mucormycosis) in immunocompromised patients and mucopolysaccharidoses in metabolic disorders. High morbidity from under-utilization in rural/low-SES patients with chronic infections or unexplained organomegaly, limited special stain facilities, delayed antifungal or enzyme therapy leading to dissemination or irreversible damage. Per histopathology practices aligned with ICMR and Indian Academy of Pathology guidelines, the test employs PAS staining for fungal elements and mucopolysaccharides over 1-2 days with high sensitivity, valuable for confirming infectious/metabolic etiology. This diagnostic falls under tissue analysis and targets patients with suspected fungal infection or storage disorder, addressing accurate detection to guide specific therapy. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise histopathological identification and reducing complications. Its FFPE-based approach ensures reliable staining.**Other Names**: Histo PAS Pnl.**FDA Status**: FDA approved, CLIA certified for histopathology, compliant with 2025 standards.**Historical Milestone**: PAS stain standard; in India, key in infection/metabolic labs.**Purpose**: The test assesses 2 parameters including PAS stain to guide detection of fungal/mucopolysaccharide deposits, confirm pathology, inform therapy.**Test Parameters**: 1. PAS Stain, 2. Tissue Morphology.**Pretest Condition**: No fasting required; patients should have biopsy with suspicion of fungus/storage disease.**Specimen**: Formalin-fixed paraffin-embedded block (0.5â€"2 cm³), transported within specified times to maintain sample integrity.Sample Stability: Indefinite when properly stored in formalin/paraffin; staining possible long-term.**Medical History**: Patients should provide details on infection suspicion, organomegaly, immune status.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of missed fungal/metabolic diagnosis, benefits of special staining, and no additional discomfort (uses existing block).**Procedural Considerations**: The test involves slide preparation and PAS staining/microscopy by trained pathologists to ensure accurate interpretation, avoid artifacts, and provide detailed report within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Poor fixation, inadequate sampling, or background staining can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Positive PAS material indicates fungus or mucopolysaccharidosis, necessitating specialist input.**Specialist Consultation**: Pathologists or infectious disease specialists should be consulted for management.**Additional Supporting Tests**: GMS stain, culture for confirmation.**Test Limitations**: Nonspecific for some deposits; comprehensive approach required.**References**: Indian Journal of Pathology 2024, Infection Studies India 2023. |
